SpringWorks Total Assets from 2010 to 2024
| SWTX Stock | USD 43.38 0.62 1.41% |
Total Assets | First Reported 2000-03-31 | Previous Quarter 467.7 M | Current Value 725.8 M | Quarterly Volatility 199.4 M |
Check SpringWorks Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SpringWorks main balance sheet or income statement drivers, such as Interest Expense of 923.7 K, Selling General Administrative of 207.4 M or Total Revenue of 5.2 M, as well as many exotic indicators such as Price To Sales Ratio of 444, Dividend Yield of 0.0 or PTB Ratio of 3.86. SpringWorks financial statements analysis is a perfect complement when working with SpringWorks Therapeutics Valuation or Volatility modules.
SpringWorks | Total Assets |
Latest SpringWorks Therapeutics' Total Assets Growth Pattern
Below is the plot of the Total Assets of SpringWorks Therapeutics over the last few years. Total assets refers to the total amount of SpringWorks Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in SpringWorks Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. SpringWorks Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in SpringWorks Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 725.79 M | 10 Years Trend |
|
Total Assets |
| Timeline |
SpringWorks Total Assets Regression Statistics
| Arithmetic Mean | 245,636,627 | |
| Geometric Mean | 65,520,338 | |
| Coefficient Of Variation | 122.04 | |
| Mean Deviation | 267,707,152 | |
| Median | 48,390,000 | |
| Standard Deviation | 299,777,673 | |
| Sample Variance | 89866.7T | |
| Range | 751.5M | |
| R-Value | 0.87 | |
| Mean Square Error | 23683.6T | |
| R-Squared | 0.76 | |
| Significance | 0.000026 | |
| Slope | 58,255,803 | |
| Total Sum of Squares | 1258133.1T |
SpringWorks Total Assets History
Other Fundumenentals of SpringWorks Therapeutics
SpringWorks Therapeutics Total Assets component correlations
Click cells to compare fundamentals
About SpringWorks Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include SpringWorks Therapeutics income statement, its balance sheet, and the statement of cash flows. SpringWorks Therapeutics investors use historical funamental indicators, such as SpringWorks Therapeutics's Total Assets, to determine how well the company is positioned to perform in the future. Although SpringWorks Therapeutics investors may use each financial statement separately, they are all related. The changes in SpringWorks Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on SpringWorks Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on SpringWorks Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in SpringWorks Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Assets | 725.8 M | 762.1 M | |
| Intangibles To Total Assets | 0.01 | 0.01 |
Currently Active Assets on Macroaxis
When determining whether SpringWorks Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SpringWorks Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Springworks Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Springworks Therapeutics Stock:Check out the analysis of SpringWorks Therapeutics Correlation against competitors. For more information on how to buy SpringWorks Stock please use our How to Invest in SpringWorks Therapeutics guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for SpringWorks Stock analysis
When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is SpringWorks Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SpringWorks Therapeutics. If investors know SpringWorks will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SpringWorks Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.15) | Revenue Per Share 0.086 | Return On Assets (0.32) | Return On Equity (0.55) |
The market value of SpringWorks Therapeutics is measured differently than its book value, which is the value of SpringWorks that is recorded on the company's balance sheet. Investors also form their own opinion of SpringWorks Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is SpringWorks Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SpringWorks Therapeutics' market value can be influenced by many factors that don't directly affect SpringWorks Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SpringWorks Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if SpringWorks Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SpringWorks Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.